MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
24h
Current
Min
5.38
Max
6
Income | -41M -65M |
---|---|
Profit margin | -82.56 |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +114.78% upside |
Next Earnings | 7 May 2025 |
---|
Past performance is not a reliable indicator of future results.
31 Dec 2024, 19:15 UTC
Verastem Shares Soar on FDA Priority Review of Cancer Treatment
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 12.5 USD 114.78%
High 20 USD
Low 9 USD
Based on 8 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
8 ratings
8
Buy
0
Hold
0
Sell
Based on 8 analysts giving stock ratings to Verastem Inc - Dist in the past 3 months.
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$